BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 24599081)

  • 1. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology and nanomedicine: going small means aiming big.
    Teli MK; Mutalik S; Rajanikant GK
    Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
    Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cell and nanotechnology-based therapeutics.
    Liu WH; Chang YL; Lo WL; Li HY; Hsiao CW; Peng CH; Chiou SH; Ma HI; Chen SJ
    Cell Transplant; 2015; 24(11):2185-95. PubMed ID: 25299513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanodelivery systems for improved topical antimicrobial therapy.
    Basnet P; Škalko-Basnet N
    Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
    Gupta A; Ahmad A; Dar AI; Khan R
    Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering precision nanoparticles for drug delivery.
    Mitchell MJ; Billingsley MM; Haley RM; Wechsler ME; Peppas NA; Langer R
    Nat Rev Drug Discov; 2021 Feb; 20(2):101-124. PubMed ID: 33277608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
    Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
    J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging applications of magnetic nanovectors in nanomedicine.
    Seeney CE
    Pharm Pat Anal; 2015; 4(4):285-304. PubMed ID: 26174567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic Nanotechnology toward Personalized Vaccines.
    Zhou J; Kroll AV; Holay M; Fang RH; Zhang L
    Adv Mater; 2020 Apr; 32(13):e1901255. PubMed ID: 31206841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
    Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.
    Radhakrishnan A; Kuppusamy G; Ponnusankar S; Shanmukhan NK
    Pharmacogenomics J; 2020 Feb; 20(1):1-18. PubMed ID: 31819163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives and opportunities for nanomedicine in the management of atherosclerosis.
    Lobatto ME; Fuster V; Fayad ZA; Mulder WJ
    Nat Rev Drug Discov; 2011 Oct; 10(11):835-52. PubMed ID: 22015921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology, from quantum mechanical calculations up to drug delivery.
    Szefler B
    Int J Nanomedicine; 2018; 13():6143-6176. PubMed ID: 30349242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Nanoparticles and their Application in Nanomedicine.
    Rajabi M; Mousa SA
    Curr Pharm Biotechnol; 2016; 17(8):662-72. PubMed ID: 27087491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro- and nanotechnology approaches to improve Parkinson's disease therapy.
    Torres-Ortega PV; Saludas L; Hanafy AS; Garbayo E; Blanco-Prieto MJ
    J Control Release; 2019 Feb; 295():201-213. PubMed ID: 30579984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine--prospective therapeutic and diagnostic applications.
    Emerich DF
    Expert Opin Biol Ther; 2005 Jan; 5(1):1-5. PubMed ID: 15709905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.